Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Syncona
Biotech
Syncona cites 'challenging' market for switching investment plan
Life sciences firm Syncona has blamed “particularly challenging” market conditions for shifting its strategy away from early-stage biotechs.
James Waldron
Jun 20, 2025 6:00am
Weight of market pressures pushes Novo CEO out—Chutes & Ladders
May 23, 2025 8:30am
Syncona adds two cancer biotechs to growing portfolio
Jun 20, 2024 8:37am
Syncona merges Freeline, SwanBio into new gene therapy biotech
Jun 17, 2024 11:01am
Syncona throws lifeline to Freeline by buying struggling biotech
Nov 22, 2023 9:40am
Freeline, facing fading cash runway, mulls buyout by Syncona
Oct 19, 2023 10:00am
